Stockreport

Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF SAN FRANCISCO, June 26, 2024 BUSINESS WIRE )--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the U.S. Food and Drug Administration (FDA) has cleared its inv [Read more]